Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 8
Submit an article Journal homepage
502
Views
35
CrossRef citations to date
0
Altmetric
Original Article

Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study

Vassilios G. AthyrosSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Asterios KaragiannisSecond Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Emmanouel S. GanotakisDepartment of Internal Medicine, Medical School, University of Crete, Heraklion, Greece
,
Konstantinos PaletasSecond Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Vassilios NicolaouFirst Cardiology Department, Red Cross Hospital, Athens, Greece
,
George BacharoudisPrimary Prevention Unit Alexandroupolis, Greece
,
Konstantinos TziomalosFirst Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Theodore AlexandridesDivision of Endocrinology, Department of Internal Medicine, University of Patras, Medical School, Rio Hospital, Patras, Greece
,
Evangelos N. LiberopoulosDepartment of Internal Medicine, Medical School, University of Ioannina, Greece
,
Dimitri P. MikhailidisDepartment of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), UKCorrespondence[email protected]
& for the Assessing The Treatment Effect in Metabolic syndrome without Perceptible diabeTes (ATTEMPT) Collaborative Group* show all
Pages 1659-1668 | Accepted 02 Jun 2011, Published online: 30 Jun 2011

Citations (35)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Vasilios G Athyros, Konstantinos Tziomalos & Asterios Karagiannis. (2015) Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy. Expert Review of Cardiovascular Therapy 13:9, pages 1059-1066.
Read now
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P Mikhailidis. (2015) Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opinion on Pharmacotherapy 16:10, pages 1449-1461.
Read now
Niki Katsiki, Michael Doumas, Vasilios G Athyros & Asterios Karagiannis. (2015) Hyperuricemia as a risk factor for cardiovascular disease. Expert Review of Cardiovascular Therapy 13:1, pages 19-20.
Read now
Sabas I Gomez, Christos G Mihos, Andres M Pineda & Orlando Santana. (2014) The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease. International Journal of Nephrology and Renovascular Disease 7, pages 123-130.
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2014) Achieving lipid targets in primary care settings. Current Medical Research and Opinion 30:10, pages 1971-1974.
Read now
Niki Katsiki, Michael Doumas, Vasilios G Athyros & Asterios Karagiannis. (2014) Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit. Expert Review of Cardiovascular Therapy 12:3, pages 295-296.
Read now
Maciej Banach. (2013) Statins in patients with chronic kidney disease – an attempt at recommendations. Current Medical Research and Opinion 29:11, pages 1419-1422.
Read now
Vassilios G. Athyros, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P. Mikhailidis. (2013) Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Current Medical Research and Opinion 29:10, pages 1263-1274.
Read now
Vasilios G. Athyros, Niki Katsiki & Asterios Karagiannis. (2013) Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients. Current Medical Research and Opinion 29:7, pages 791-792.
Read now
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P Mikhailidis. (2012) Stage of chronic kidney disease and severity of coronary heart disease manifestation. Expert Opinion on Pharmacotherapy 13:4, pages 457-460.
Read now

Articles from other publishers (25)

Atalay Demiray, Baris Afsar, Adrian Covic, Masanari Kuwabara, Charles J. Ferro, Miguel A. Lanaspa, Richard J. Johnson & Mehmet Kanbay. (2021) The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review. Angiology 73:1, pages 9-17.
Crossref
Emilia Siemińska, Przemysław Sobczak, Natalia Skibińska & Joanna Sikora. (2020) The differential role of uric acid – The purpose or cause of cardiovascular diseases?. Medical Hypotheses 142, pages 109791.
Crossref
Sehoon Park, Soojin Lee, Yaerim Kim, Yeonhee Lee, Min Woo Kang, Kyungdo Han, Hajeong Lee, Jung Pyo Lee, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim & Dong Ki Kim. (2020) Reduced risk for chronic kidney disease after recovery from metabolic syndrome: A nationwide population-based study. Kidney Research and Clinical Practice 39:2, pages 180-191.
Crossref
Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Alexandros Sachinidis, Michalis Doumas & Vasilios Athyros. (2020) Hypertension in Metabolic Syndrome: Novel Insights. Current Hypertension Reviews 16:1, pages 12-18.
Crossref
Uğur Canpolat, Cem Çöteli & Ahmet Kivrak. (2016) Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?. Angiology 68:7, pages 648-649.
Crossref
Aminu K. Bello, Bilal Qarni, Arian Samimi, Julius Okel, Trish Chatterley, Ikechi G. Okpechi, Ben Vandermeer & Branko Braam. (2017) Effectiveness of Multifaceted Care Approach on Adverse Clinical Outcomes in Nondiabetic CKD: A Systematic Review and Meta-analysis. Kidney International Reports 2:4, pages 617-625.
Crossref
Xiaole Su, Lu Zhang, Jicheng Lv, Jinwei Wang, Wanyin Hou, Xinfang Xie & Hong Zhang. (2016) Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 67:6, pages 881-892.
Crossref
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P Mikhailidis. (2015) Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 21:22, pages 6820-6834.
Crossref
Konstantinos Kargiotis. (2015) Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World Journal of Gastroenterology 21:25, pages 7860.
Crossref
Yong Un Kang, Ha Yeon Kim, Joon Seok Choi, Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma & Soo Wan Kim. (2014) Metabolic Syndrome and Chronic Kidney Disease in an Adult Korean Population: Results from the Korean National Health Screening. PLoS ONE 9:5, pages e93795.
Crossref
Vasilios G. Athyros & Dimitri P. Mikhailidis. (2014) Uric acid, chronic kidney disease and type 2 diabetes: A cluster of vascular risk factors. Journal of Diabetes and its Complications 28:2, pages 122-123.
Crossref
Vasilios Athyros, Andromachi Reklou, Antonis Lazarides, Eudoxia Mitsiou & Asterios Karagiannis. (2013) Effect of Cardio-Metabolic Risk Factors Clustering with or without Arterial Hypertension on Arterial Stiffness: A Narrative Review. Diseases 1:1, pages 51-72.
Crossref
Dragana Nikolic, Maciej Banach, Shekoufeh Nikfar, Pooneh Salari, Dimitri P. Mikhailidis, Peter P. Toth, Mohammad Abdollahi, Kausik K. Ray, Michael J. Pencina, Jolanta Malyszko, Jacek Rysz & Manfredi Rizzo. (2013) A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?. International Journal of Cardiology 168:6, pages 5437-5447.
Crossref
Niki Katsiki, Asterios Karagiannis, Vasilios G. Athyros & Dimitri P. Mikhailidis. (2013) Hyperuricaemia. Journal of Cardiovascular Medicine 14:6, pages 397-402.
Crossref
A. Kei, E. N. Liberopoulos, D. P. Mikhailidis & M. Elisaf. (2013) Comparison of switch to the highest dose of rosuvastatin vs. add-on nicotinic acid vs. add-on fenofibrate for mixed dyslipidaemia. International Journal of Clinical Practice 67:5, pages 412-419.
Crossref
Anna Gluba, Dimitri P. Mikhailidis, Gregory Y.H. Lip, Simon Hannam, Jacek Rysz & Maciej Banach. (2013) Metabolic syndrome and renal disease. International Journal of Cardiology 164:2, pages 141-150.
Crossref
Elisavet Moutzouri, Evangelos N. Liberopoulos, Matilda Florentin, George Liamis & Moses S. Elisaf. (2012) Effects of Statin Monotherapy Versus Statin Plus Ezetimibe Combination on Serum Uric Acid Levels. Journal of Cardiovascular Pharmacology and Therapeutics 18:1, pages 13-18.
Crossref
Zhaoxia Yin, Zhe Fang, Ming Yang, Xueping Du, Bin Nie & Kang Gao. (2013) Predictive Value of Serum Uric Acid Levels on Mortality in Acute Coronary Syndrome Patients with Chronic Kidney Disease after Drug-Eluting Stent Implantation. Cardiology 125:4, pages 204-212.
Crossref
Vasilios G Athyros & Dimitri P Mikhailidis. (2012) Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters. The Open Cardiovascular Medicine Journal 6:1, pages 122-125.
Crossref
Anna Gluba, Agata Bielecka, Dimitri P. Mikhailidis, Nathan D. Wong, Stanley S. Franklin, Jacek Rysz & Maciej Banach. (2012) An update on biomarkers of heart failure in hypertensive patients. Journal of Hypertension 30:9, pages 1681-1689.
Crossref
Mustafa Duran, Nihat Kalay, Mahmut Akpek, Ozcan Orscelik, Deniz Elcik, Ayse Ocak, Mehmet Tugrul Inanc, H. Ahmet Kasapkara, Abdurrahman Oguzhan, Namik K. Eryol, Ali Ergin & Mehmet Gungor Kaya. (2011) High Levels of Serum Uric Acid Predict Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome. Angiology 63:6, pages 448-452.
Crossref
Hisato Takagi & Takuya Umemoto. (2012) Atorvastatin therapy reduces serum uric acid levels: A meta-analysis of randomized controlled trials. International Journal of Cardiology 157:2, pages 255-257.
Crossref
Vasilios G. Athyros, Asterios Karagiannis, Niki Katsiki & Dimitri P. Mikhailidis. (2012) Statins in Patients With Renal Dysfunction. The American Journal of Cardiology 109:10, pages 1537.
Crossref
Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P. Mikhailidis. (2012) Should raising high-density lipoprotein cholesterol be a matter of debate?. Journal of Cardiovascular Medicine 13:4, pages 254-259.
Crossref
Vasilios G Athyros, Niki Katsiki, Konstantinos Tziomalos & Asterios Karagiannis. (2011) Editorial: Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?. The Open Cardiovascular Medicine Journal 5:1, pages 226-230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.